Gene Location [1]
Receptor tyrosine kinase/growth factor signaling

MET Mutation is present in 1.90% of AACR GENIE cases, with lung adenocarcinoma, cutaneous melanoma, colon adenocarcinoma, melanoma, and endometrial endometrioid adenocarcinoma having the greatest prevalence [4].

Top Disease Cases with MET Mutation

Significance of MET Mutation in Diseases

Malignant Solid Tumor +

Non-Small Cell Lung Carcinoma +

Breast Carcinoma +

Colorectal Carcinoma +

Melanoma +

Head And Neck Squamous Cell Carcinoma +

Cancer +

Hepatocellular Carcinoma +

Glioblastoma +

Renal Cell Carcinoma +

Squamous Cell Lung Carcinoma +

Prostate Carcinoma +

Endometrial Carcinoma +

Bladder Carcinoma +

Head And Neck Carcinoma +

Non-Hodgkin Lymphoma +

Ovarian Carcinoma +

Pancreatic Carcinoma +

Urothelial Carcinoma +

Gastric Adenocarcinoma +

Lymphoma +

Ewing Sarcoma +

Soft Tissue Sarcoma +

Osteosarcoma +

Papillary Renal Cell Carcinoma +

Malignant Uterine Neoplasm +

Undifferentiated Pleomorphic Sarcoma +

Lung Carcinoma +

Small Cell Lung Carcinoma +

Cervical Squamous Cell Carcinoma +

Glioma +

Desmoid-Type Fibromatosis +

Cervical Carcinoma +

Anaplastic Astrocytoma +

Gastric Carcinoma +

Gliosarcoma +

Esophageal Squamous Cell Carcinoma +

Chondrosarcoma +

High Grade Ovarian Serous Adenocarcinoma +

Adenocarcinoma Of The Gastroesophageal Junction +

Medulloblastoma +

Oropharyngeal Squamous Cell Carcinoma +

Peritoneal Mesothelioma +

Hematologic And Lymphocytic Disorder +

Mesothelioma +

Sarcoma +

Multiple Myeloma +

Pancreatic Adenocarcinoma +

Gallbladder Carcinoma +

Thyroid Gland Carcinoma +

B-Cell Non-Hodgkin Lymphoma +

Thyroid Gland Medullary Carcinoma +

Adrenal Cortex Carcinoma +

Hematopoietic And Lymphoid System Neoplasm +

Bile Duct Carcinoma +

Cholangiocarcinoma +

Hematopoietic And Lymphoid Malignancy +

Rhabdomyosarcoma +

Histiocytic And Dendritic Cell Neoplasm +

Myelodysplastic Syndromes +

Liposarcoma +

Myeloid Neoplasm +

Aggressive Systemic Mastocytosis +

Alveolar Soft Part Sarcoma +

Bronchogenic Carcinoma +

Classical Hodgkin Lymphoma +

Clear Cell Sarcoma Of Soft Tissue +

Diffuse Intrinsic Pontine Glioma +

Hepatoblastoma +

Mast Cell Leukemia +

Pecoma +

Systemic Mastocytosis With An Associated Hematological Neoplasm (SM-AHN) +

Wilms Tumor +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.